|
NPPA
seeks more teeth, Govt agrees in principle
Faced
with resistance from individual companies on the implementation
front, the National Pharmaceutical Pricing Authority (NPPA) is now
seeking more enforcement powers.
Ranbaxy
obtains clearance for mycophenolate mofetil
Ranbaxy Laboratories is soon expected to make its foray into the
biogeneric segment with the launch of immunosuppressant drug mycophenolate
mofetil. Ranbaxy has already secured marketing clearance from the
DCGI, it is learnt.
Maharashtra
FDA gears up to implement new GMP Rules
The
Maharashtra Food and Drug Administration (FDA) is drawing up a detailed
action plan to meet the challenges of implementing the new GMP Rules
(Schedule M amendments) enacted by the Central Government.
|
|
New
product launches in 2001: Coping with failures
The
Indian Pharma Industry: Beyond ’05 
